Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

ThermoGenesis Holdings celebrates its 35th anniversary as a cell and gene therapy-focused company

ThermoGenesis Holdings celebrates its 35th anniversary as a cell and gene therapy-focused company

ThermoGenesis Holdings, Inc. (NASDAQ: THMO) Chief Technology Officer and co-founder Phil Coelho tells Proactive the Rancho Cordova, California-based cell and gene therapy-focused group is celebrating its 35th anniversary.

Coelho touched on the group's latest achievements in the cell and gene therapy space including the recent launch of its PXP-LAVARE System, developed as a cell washing and reformulation system.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK